These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4306594)

  • 21. The influence of topical vaginal estrogen application on the lipids metabolism.
    Blum M; Werchow ME; Yeshurun D
    Gynecol Obstet Invest; 1983; 15(1):10-5. PubMed ID: 6295895
    [No Abstract]   [Full Text] [Related]  

  • 22. A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestin.
    Milner MH; Sinnott MM; Cooke TM; Kelly A; McGill T; Harrison RF
    Obstet Gynecol; 1996 Apr; 87(4):593-9. PubMed ID: 8602314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Behaviour of serum lipids in the pathogenesis of posttraumatic fat embolism].
    Mörl FK; Heller W
    Bruns Beitr Klin Chir (1971); 1969 Mar; 217(2):132-40. PubMed ID: 5373695
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment with conjugated estrogens].
    Bickenbach W; Lang N
    Munch Med Wochenschr; 1966 Sep; 108(35):1721-5. PubMed ID: 4298376
    [No Abstract]   [Full Text] [Related]  

  • 25. [Regulatory action of lyophilized pancreatic powder on lipemia and serum fatty acids].
    Bonhomme Y; Mallein R; Bertrand JL; Brette R
    Nouv Presse Med; 1973 Jul; 2(27):1860. PubMed ID: 4719848
    [No Abstract]   [Full Text] [Related]  

  • 26. [Modification of C3 and C4 levels after the administration of conjugated estrogens plus medroxiprogesterone or raloxifene in postmenopausal women].
    Carranza Lira S; MacGregor Gooch AL; Olivares A; González Legorreta SL; Saldívar N; Martínez Chéquer JC
    Ginecol Obstet Mex; 2005 Oct; 73(10):521-4. PubMed ID: 16583831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Climacteric symptom control after the addition of low-dose esterified conjugated estrogens to raloxifene standard doses.
    Carranza-Lira S; Gooch AL; Saldivar N; Osterwalder MS
    Int J Fertil Womens Med; 2007; 52(2-3):93-6. PubMed ID: 18320867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of raloxifene and hormone therapy on serum markers of brain and whole-body cholesterol metabolism in postmenopausal women.
    Vogelvang TE; Mijatovic V; van der Mooren MJ; Pinsdorf U; von Bergmann K; Netelenbos JC; Lütjohann D
    Maturitas; 2005 Apr; 50(4):312-20. PubMed ID: 15780532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Action of "essential" phospholipids on plasma lipids and fatty acids in type II hyperlipoproteinemias].
    Peeters H; Blaton V; Soetewey F; Declercq B; Vandamme D
    Munch Med Wochenschr; 1973 Aug; 115(31):1358-62. PubMed ID: 4741079
    [No Abstract]   [Full Text] [Related]  

  • 30. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
    Baracat EC; Barbosa IC; Giordano MG; Haidar MA; Marinho RM; Menegocci JC; Morais KM; Tomaz G; Wehba S
    Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes of the blood lipid pattern in diabetics under treatment with chlorpropamide and phenethyl-1-biguanide].
    Meduri D; Polito R
    Minerva Med; 1969 Jun; 60(49):2439-48. PubMed ID: 5802656
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables.
    Kroon UB; Silfverstolpe G; Tengborn L
    Thromb Haemost; 1994 Apr; 71(4):420-3. PubMed ID: 8052956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levels and composition of serum depot lipids in Barraquer-Simons' disease.
    De Leo T; Iacono G; Caccia Perugini I; Gualà L
    Folia Endocrinol; 1967 Apr; 20(2):247-54. PubMed ID: 5630522
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
    Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
    Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amenorrhea and endometrial atrophy.
    Fribourg S
    Obstet Gynecol; 1985 Dec; 66(6):836-7. PubMed ID: 2999662
    [No Abstract]   [Full Text] [Related]  

  • 36. [Postmenopausal hormone substitution and its effects on the climacteric syndrome, body weight and blood pressure].
    Fritsch H; Fritsch W; Julius U; Rehak E; Wieczorek A; Hanefeld M
    Zentralbl Gynakol; 1997; 119(3):128-32. PubMed ID: 9173771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The treatment of climacteric complaints with Ovaribran in gynecological practice].
    Wild KH
    Z Allgemeinmed; 1969 May; 45(15):722-4. PubMed ID: 4308149
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of natural estrogens and diazepam alone and in combination on the climacteric syndrome].
    Horský J
    MMW Munch Med Wochenschr; 1979 Jun; 121(22):765-6. PubMed ID: 224313
    [No Abstract]   [Full Text] [Related]  

  • 39. [II. Histology of the ovary in women treated with 3.75 mg of conjugated estrogens during 20 days].
    Dabancens A; Fuensalida S; González O
    Rev Chil Obstet Ginecol; 1976; 41(6):337-40. PubMed ID: 208112
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of conjugated oestrogen therapy on circulating luteinising hormone in oophorectomised women.
    Utian WH; Vinik AI; Bearwood CJ; Beumont PJ
    S Afr Med J; 1975 May; 49(20):821-2. PubMed ID: 168645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.